Caroline Litchfield - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP & CFO
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Caroline Litchfield
Issuer symbol
MRK
Transactions as of
30 Apr 2024
Net transactions value
$0
Form type
4
Filing time
02 May 2024, 16:07:21 UTC
Previous filing
15 Feb 2024
Next filing
03 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 50,908 30 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +49,805 $0.000000 49,805 30 Apr 2024 Common Stock 49,805 $129.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.